The Effect of Depressive Symptoms on Adherence to Daily Oral PrEP in Men who have Sex with Men and Transgender Women: A Marginal Structural Model Analysis of The iPrEx OLE Study-Reference-Cited by-同舟云学术

The Effect of Depressive Symptoms on Adherence to Daily Oral PrEP in Men who have Sex with Men and Transgender Women: A Marginal Structural Model Analysis of The iPrEx OLE Study

Published:2016-04-28 Issue:7 Volume:20 Page:1527-1534
ISSN:1090-7165
Container-title:AIDS and Behavior
language:en
Short-container-title:AIDS Behav

Author:

Mehrotra Megha L.,Glidden David V.,McMahan Vanessa,Amico K. Rivet,Hosek Sybil,Defechereux Patricia,Mayer Kenneth H.,Veloso Valdilea G.,Bekker Linda-Gail,Avelino-Silva Vivian I.,Schechter Mauro,Grant Robert M.

Funder

National Institute of Allergy and Infectious Diseases

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,Social Psychology

Link

http://link.springer.com/content/pdf/10.1007/s10461-016-1415-9.pdf

Reference41 articles.

1. Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587–99.

2. Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, et al. Antiretroviral prophylaxis for HIV-1 prevention among heterosexual men and women. N Engl J Med. 2012;367(5):399–410.

3. Choopanya K, Martin M, Suntharasamai P, Sangkum U, Mock PA, Leethochawalit M, et al. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial. The Lancet. 2013;381(9883):2083–90.